These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38721086)

  • 1. Availability of Serum Levels of Carbohydrate Antigen 19-9 (CA19-9) as a Surrogate Tumor Marker for Papillary Thyroid Carcinoma.
    Kihara M; Miyauchi A; Hirokawa M; Suzuki A; Akamizu T
    JMA J; 2024 Apr; 7(2):250-257. PubMed ID: 38721086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic papillary thyroid carcinoma presenting with elevated serum levels of carbohydrate antigen 19-9 (CA19-9): a case report.
    Kihara M; Miyauchi A; Hirokawa M; Fujishima M; Masuoka H; Higashiyama T; Onoda N; Ito Y; Miya A
    Surg Case Rep; 2022 Mar; 8(1):45. PubMed ID: 35292876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum thyroglobulin antibody levels as a dynamic prognostic factor for early-phase recurrence of thyroglobulin antibody-positive papillary thyroid carcinoma after total thyroidectomy.
    Yamada O; Miyauchi A; Ito Y; Nakayama A; Yabuta T; Masuoka H; Fukushima M; Higashiyama T; Kihara M; Kobayashi K; Miya A
    Endocr J; 2014; 61(10):961-5. PubMed ID: 25029954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of changes in serum thyroglobulin antibody levels of pre- and post-total thyroidectomy in thyroglobulin antibody-positive papillary thyroid carcinoma patients.
    Tsushima Y; Miyauchi A; Ito Y; Kudo T; Masuoka H; Yabuta T; Fukushima M; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Kikumori T; Imai T; Kiuchi T
    Endocr J; 2013; 60(7):871-6. PubMed ID: 23585494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In search of an unstimulated thyroglobulin baseline value in low-risk papillary thyroid carcinoma patients not receiving radioactive iodine ablation.
    Angell TE; Spencer CA; Rubino BD; Nicoloff JT; LoPresti JS
    Thyroid; 2014 Jul; 24(7):1127-33. PubMed ID: 24697314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
    Spencer CA
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3615-27. PubMed ID: 21917876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma.
    Jeon MJ; Park JW; Han JM; Yim JH; Song DE; Gong G; Kim TY; Baek JH; Lee JH; Shong YK; Kim WB
    J Clin Endocrinol Metab; 2013 Jan; 98(1):153-60. PubMed ID: 23144473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PROGNOSIS OF HIGH-RISK PAPILLARY THYROID CANCER PATIENTS WITH PRE-ABLATION STIMULATED TG <1 NG/ML.
    Tian T; Kou Y; Huang R; Liu B
    Endocr Pract; 2019 Mar; 25(3):220-225. PubMed ID: 30913010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3974-82. PubMed ID: 22948755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential changes of serum antithyroglobulin antibody levels are a good predictor of disease activity in thyroglobulin-negative patients with papillary thyroid carcinoma.
    Hsieh CJ; Wang PW
    Thyroid; 2014 Mar; 24(3):488-93. PubMed ID: 23971786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroglobulin antibody levels do not predict disease status in papillary thyroid cancer.
    Smooke-Praw S; Ro K; Levin O; Ituarte PH; Harari A; Yeh MW
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):271-5. PubMed ID: 24494778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosis.
    Viola N; Agate L; Caprio S; Lorusso L; Brancatella A; Ricci D; Sgrò D; Ugolini C; Piaggi P; Vitti P; Elisei R; Santini F; Latrofa F
    Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA19-9 producing locally advanced papillary thyroid carcinoma: a case report.
    Morikawa H; Oba T; Kitazawa A; Iji R; Kiyosawa N; Amitani M; Shimizu T; Kanai T; Uehara T; Ito KI
    Surg Case Rep; 2024 Apr; 10(1):83. PubMed ID: 38598167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized Follow-Up Strategy for Patients with an Indeterminate Response to Initial Therapy for Papillary Thyroid Carcinoma.
    Oh HS; Ahn JH; Song E; Han JM; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
    Thyroid; 2019 Feb; 29(2):209-215. PubMed ID: 30384812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlations of serum TgAb and TPOAb and clinicopathological features of PTC in children and adolescents].
    Huang DM; Zhi JT; Zhang JM; Zheng XQ; Zhao JZ; Wei SF; Gao M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1418-1425. PubMed ID: 36707945
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum antithyroglobulin antibody levels are not a good predictive factor on detection of disease activity in patients with papillary thyroid carcinoma.
    Turanli S; Mersin HH
    J Cancer Res Ther; 2020; 16(3):624-629. PubMed ID: 32719278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in Antithyroglobulin Antibody Levels is a Good Predictor of Responses to Therapy in Antithyroglobulin Antibody-Positive Pediatric Papillary Thyroid Carcinoma Patients.
    Xi C; Zhang GQ; Song HJ; Shen CT; Hou LY; Qiu ZL; Luo QY
    Int J Endocrinol; 2022; 2022():7173919. PubMed ID: 35311033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of positive thyroglobulin antibodies on the prognosis and treatment response in patients with papillary thyroid carcinoma.
    Sanjari M; Ordooei M; Amirkhosravi L; Naghibzadeh-Tahami A; Nazemi S
    Heliyon; 2024 Feb; 10(4):e26092. PubMed ID: 38384522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node fine-needle aspiration washout thyroglobulin in papillary thyroid cancer: Diagnostic value and the effect of thyroglobulin antibodies.
    Konca Degertekin C; Yalcin MM; Cerit T; Ozkan C; Kalan I; Iyidir OT; Altinova AE; Akturk M; Toruner F; Akin M; Cakir N
    Endocr Res; 2016 Nov; 41(4):281-289. PubMed ID: 26905960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.